🇪🇺 Novolog in European Union

EMA authorised Novolog on 7 September 1999

Marketing authorisation

EMA — authorised 7 September 1999

  • Marketing authorisation holder: NovoRapid
  • Status: approved

Novolog in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Novolog approved in European Union?

Yes. EMA authorised it on 7 September 1999.

Who is the marketing authorisation holder for Novolog in European Union?

NovoRapid holds the EU marketing authorisation.